Search | VHL Regional Portal

Left ventricular partitioning device in a patient with chronic heart failure: short-term clinical follow-up.

Bozdag-Turan, I; Bermaoui, B; Turan, R G; Paranskaya, L; D'Ancona, G; Kische, S; Hauenstein, K; Nienaber, C A; Ince, H.

Int J Cardiol ; 163(1): e1-3, 2013 Feb 10.

Article in English | MEDLINE | ID: mdl-22824252

Subject(s)

Cardiac Catheterization/instrumentation , Cardiac Catheterization/methods , Heart Failure/diagnostic imaging , Heart Failure/therapy , Heart Ventricles/diagnostic imaging , Aged , Follow-Up Studies , Humans , Male , Time Factors , Ultrasonography

Mitral valve with three orifices after percutaneous repair with the MitraClip system: the triple-orifice technique.

Paranskaya, L; Kische, S; Bozdag-Turan, I; Nienaber, C; Ince, H.

Clin Res Cardiol ; 101(10): 847-9, 2012 Oct.

Article in English | MEDLINE | ID: mdl-22466759

Subject(s)

Mitral Valve Insufficiency/surgery , Mitral Valve/surgery , Aged , Equipment Design , Female , Follow-Up Studies , Humans , Mitral Valve/pathology , Mitral Valve Insufficiency/pathology , Risk Factors , Treatment Outcome

[Dynamic left ventricular outflow tract obstruction in pulmonary embolism]. / Dynamische Obstruktion des linksventrikulären Ausflusstrakts bei Lungenembolie.

Paranskaya, L; Bozdag-Turan, I; Kische, S; Akin, I; Turan, G; Nienaber, C; Ince, H.

Internist (Berl) ; 53(6): 751-5, 2012 Jun.

Article in German | MEDLINE | ID: mdl-22450772

ABSTRACT

Left ventricular hypertrophy, dehydration, sepsis, vasodilatation, excessive sympathetic stimulation, pericardial tamponade and surgical treatment of the atrioventricular valve are known causes of left ventricular outflow tract (LVOT) obstruction. We report the rare case of a patient who developed dynamic LVOT obstruction as a complication of acute pulmonary embolism.

Subject(s)

Pulmonary Embolism/complications , Pulmonary Embolism/diagnosis , Ventricular Outflow Obstruction/diagnosis , Ventricular Outflow Obstruction/etiology , Aged , Diagnosis, Differential , Fibrinolytic Agents/therapeutic use , Humans , Male , Pulmonary Embolism/drug therapy , Thrombolytic Therapy , Treatment Outcome , Ventricular Outflow Obstruction/drug therapy

Subject(s)

Subject(s)

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL